Industry Urges UK, EU, To Safeguard Medicines Regulation During Post-Brexit Transition 28/11/2017 William New Associations representing the life sciences industry in the United Kingdom and Europe today issued a call for cooperation on regulation between the UK and European Union on medicines regulation. Continue reading -> WHO Draft Work Program To Be Presented, Discussed 21/11/2017 Catherine Saez The World Health Organization is presenting its draft work program for 2019-2023 for consideration by member states this week. Continue reading -> Brexit Drives European Medicines Agency To The Netherlands, Move By March 2019 21/11/2017 Catherine Saez As a consequence of the decision of the United Kingdom to go its separate way, the remaining European Union member states decided yesterday that the European Medicines Agency should move to Amsterdam by the end of March 2019. Continue reading -> US NAFTA Negotiating Objectives For IP: Go Big On Digital IP Protection, Fend Off GIs 20/11/2017 William New The Office of the United States Trade Representative (USTR) has issued a set of negotiating objectives for renegotiating the 1994 North American Free Trade Agreement (NAFTA) that include its hopes for elevating intellectual property in the trade deal. Included in the list: force Canada and Mexico to ratify international treaties, accept US law on IP protection and create conditions for "strong" IP enforcement especially online, and ensure ample protection for products with generic names. Perhaps oddly, there is only one mention of trade, which includes respect for a 2001 text at the World Trade Organization on IP and public health. Continue reading -> WIPO Vaccines Report Contestable, With UN High-Level Panel Misquoted, Advocate Says 10/11/2017 Catherine Saez The World Intellectual Property Organization this week held an event that delved into research, markets and access for vaccines with panels that showed unusual breadth of representation for the UN IP agency. But health advocates have taken issue with the wording of a report released by WIPO at the event. Continue reading -> MSF Secures Deals For Key Hepatitis C Medicines, Price A Fraction Of Branded Drug 31/10/2017 Catherine Saez Médecins Sans Frontières (MSF, Doctors Without Borders) announced today that it has secured deals for two key generic hepatitis C medicines, dropping prices dramatically. Continue reading -> Health Group Challenges Gilead Patents In The US On Grounds Of Lack Of Novelty 25/10/2017 Catherine Saez A health advocacy group today announced that it has challenged a set of United States patents for a hepatitis C medicine. The group says drug maker Gilead Sciences has obtained unmerited patents for sofosbuvir, blocking millions of US patients from affordable treatment. Continue reading -> CARB-X Makes Award For First Topical Antimicrobial; Could Be Used In Emergency Settings 24/10/2017 William New CARB-X, an initiative aimed at accelerating innovation in antibacterial treatment, today announced an award to a company to accelerate development of a new bioengineered antimicrobial intended to be applied directly to affected tissues. This follows an announcement earlier this month of funding another firm to develop a new antibiotic class to treat drug-resistant Gram-negative bacterial infections. Continue reading -> WHO Establishes High-Level Commission On Noncommunicable Diseases 10/10/2017 William New The UN World Health Organization today announced it has established a new high-level global commission on noncommunicable diseases, to be chaired by former WHO director general candidate Sania Nishtar of Pakistan. Continue reading -> 2017 Social Forum Focuses On HIV, Other Epidemics, Access To Health 29/09/2017 Catherine Saez The 2017 Social Forum, an annual meeting convened by the Human Rights Council, is being held next week in Geneva, and will focus on the promotion and protection of human rights in the context of the HIV epidemic and other communicable diseases and epidemics. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Draft Work Program To Be Presented, Discussed 21/11/2017 Catherine Saez The World Health Organization is presenting its draft work program for 2019-2023 for consideration by member states this week. Continue reading -> Brexit Drives European Medicines Agency To The Netherlands, Move By March 2019 21/11/2017 Catherine Saez As a consequence of the decision of the United Kingdom to go its separate way, the remaining European Union member states decided yesterday that the European Medicines Agency should move to Amsterdam by the end of March 2019. Continue reading -> US NAFTA Negotiating Objectives For IP: Go Big On Digital IP Protection, Fend Off GIs 20/11/2017 William New The Office of the United States Trade Representative (USTR) has issued a set of negotiating objectives for renegotiating the 1994 North American Free Trade Agreement (NAFTA) that include its hopes for elevating intellectual property in the trade deal. Included in the list: force Canada and Mexico to ratify international treaties, accept US law on IP protection and create conditions for "strong" IP enforcement especially online, and ensure ample protection for products with generic names. Perhaps oddly, there is only one mention of trade, which includes respect for a 2001 text at the World Trade Organization on IP and public health. Continue reading -> WIPO Vaccines Report Contestable, With UN High-Level Panel Misquoted, Advocate Says 10/11/2017 Catherine Saez The World Intellectual Property Organization this week held an event that delved into research, markets and access for vaccines with panels that showed unusual breadth of representation for the UN IP agency. But health advocates have taken issue with the wording of a report released by WIPO at the event. Continue reading -> MSF Secures Deals For Key Hepatitis C Medicines, Price A Fraction Of Branded Drug 31/10/2017 Catherine Saez Médecins Sans Frontières (MSF, Doctors Without Borders) announced today that it has secured deals for two key generic hepatitis C medicines, dropping prices dramatically. Continue reading -> Health Group Challenges Gilead Patents In The US On Grounds Of Lack Of Novelty 25/10/2017 Catherine Saez A health advocacy group today announced that it has challenged a set of United States patents for a hepatitis C medicine. The group says drug maker Gilead Sciences has obtained unmerited patents for sofosbuvir, blocking millions of US patients from affordable treatment. Continue reading -> CARB-X Makes Award For First Topical Antimicrobial; Could Be Used In Emergency Settings 24/10/2017 William New CARB-X, an initiative aimed at accelerating innovation in antibacterial treatment, today announced an award to a company to accelerate development of a new bioengineered antimicrobial intended to be applied directly to affected tissues. This follows an announcement earlier this month of funding another firm to develop a new antibiotic class to treat drug-resistant Gram-negative bacterial infections. Continue reading -> WHO Establishes High-Level Commission On Noncommunicable Diseases 10/10/2017 William New The UN World Health Organization today announced it has established a new high-level global commission on noncommunicable diseases, to be chaired by former WHO director general candidate Sania Nishtar of Pakistan. Continue reading -> 2017 Social Forum Focuses On HIV, Other Epidemics, Access To Health 29/09/2017 Catherine Saez The 2017 Social Forum, an annual meeting convened by the Human Rights Council, is being held next week in Geneva, and will focus on the promotion and protection of human rights in the context of the HIV epidemic and other communicable diseases and epidemics. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Brexit Drives European Medicines Agency To The Netherlands, Move By March 2019 21/11/2017 Catherine Saez As a consequence of the decision of the United Kingdom to go its separate way, the remaining European Union member states decided yesterday that the European Medicines Agency should move to Amsterdam by the end of March 2019. Continue reading -> US NAFTA Negotiating Objectives For IP: Go Big On Digital IP Protection, Fend Off GIs 20/11/2017 William New The Office of the United States Trade Representative (USTR) has issued a set of negotiating objectives for renegotiating the 1994 North American Free Trade Agreement (NAFTA) that include its hopes for elevating intellectual property in the trade deal. Included in the list: force Canada and Mexico to ratify international treaties, accept US law on IP protection and create conditions for "strong" IP enforcement especially online, and ensure ample protection for products with generic names. Perhaps oddly, there is only one mention of trade, which includes respect for a 2001 text at the World Trade Organization on IP and public health. Continue reading -> WIPO Vaccines Report Contestable, With UN High-Level Panel Misquoted, Advocate Says 10/11/2017 Catherine Saez The World Intellectual Property Organization this week held an event that delved into research, markets and access for vaccines with panels that showed unusual breadth of representation for the UN IP agency. But health advocates have taken issue with the wording of a report released by WIPO at the event. Continue reading -> MSF Secures Deals For Key Hepatitis C Medicines, Price A Fraction Of Branded Drug 31/10/2017 Catherine Saez Médecins Sans Frontières (MSF, Doctors Without Borders) announced today that it has secured deals for two key generic hepatitis C medicines, dropping prices dramatically. Continue reading -> Health Group Challenges Gilead Patents In The US On Grounds Of Lack Of Novelty 25/10/2017 Catherine Saez A health advocacy group today announced that it has challenged a set of United States patents for a hepatitis C medicine. The group says drug maker Gilead Sciences has obtained unmerited patents for sofosbuvir, blocking millions of US patients from affordable treatment. Continue reading -> CARB-X Makes Award For First Topical Antimicrobial; Could Be Used In Emergency Settings 24/10/2017 William New CARB-X, an initiative aimed at accelerating innovation in antibacterial treatment, today announced an award to a company to accelerate development of a new bioengineered antimicrobial intended to be applied directly to affected tissues. This follows an announcement earlier this month of funding another firm to develop a new antibiotic class to treat drug-resistant Gram-negative bacterial infections. Continue reading -> WHO Establishes High-Level Commission On Noncommunicable Diseases 10/10/2017 William New The UN World Health Organization today announced it has established a new high-level global commission on noncommunicable diseases, to be chaired by former WHO director general candidate Sania Nishtar of Pakistan. Continue reading -> 2017 Social Forum Focuses On HIV, Other Epidemics, Access To Health 29/09/2017 Catherine Saez The 2017 Social Forum, an annual meeting convened by the Human Rights Council, is being held next week in Geneva, and will focus on the promotion and protection of human rights in the context of the HIV epidemic and other communicable diseases and epidemics. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
US NAFTA Negotiating Objectives For IP: Go Big On Digital IP Protection, Fend Off GIs 20/11/2017 William New The Office of the United States Trade Representative (USTR) has issued a set of negotiating objectives for renegotiating the 1994 North American Free Trade Agreement (NAFTA) that include its hopes for elevating intellectual property in the trade deal. Included in the list: force Canada and Mexico to ratify international treaties, accept US law on IP protection and create conditions for "strong" IP enforcement especially online, and ensure ample protection for products with generic names. Perhaps oddly, there is only one mention of trade, which includes respect for a 2001 text at the World Trade Organization on IP and public health. Continue reading -> WIPO Vaccines Report Contestable, With UN High-Level Panel Misquoted, Advocate Says 10/11/2017 Catherine Saez The World Intellectual Property Organization this week held an event that delved into research, markets and access for vaccines with panels that showed unusual breadth of representation for the UN IP agency. But health advocates have taken issue with the wording of a report released by WIPO at the event. Continue reading -> MSF Secures Deals For Key Hepatitis C Medicines, Price A Fraction Of Branded Drug 31/10/2017 Catherine Saez Médecins Sans Frontières (MSF, Doctors Without Borders) announced today that it has secured deals for two key generic hepatitis C medicines, dropping prices dramatically. Continue reading -> Health Group Challenges Gilead Patents In The US On Grounds Of Lack Of Novelty 25/10/2017 Catherine Saez A health advocacy group today announced that it has challenged a set of United States patents for a hepatitis C medicine. The group says drug maker Gilead Sciences has obtained unmerited patents for sofosbuvir, blocking millions of US patients from affordable treatment. Continue reading -> CARB-X Makes Award For First Topical Antimicrobial; Could Be Used In Emergency Settings 24/10/2017 William New CARB-X, an initiative aimed at accelerating innovation in antibacterial treatment, today announced an award to a company to accelerate development of a new bioengineered antimicrobial intended to be applied directly to affected tissues. This follows an announcement earlier this month of funding another firm to develop a new antibiotic class to treat drug-resistant Gram-negative bacterial infections. Continue reading -> WHO Establishes High-Level Commission On Noncommunicable Diseases 10/10/2017 William New The UN World Health Organization today announced it has established a new high-level global commission on noncommunicable diseases, to be chaired by former WHO director general candidate Sania Nishtar of Pakistan. Continue reading -> 2017 Social Forum Focuses On HIV, Other Epidemics, Access To Health 29/09/2017 Catherine Saez The 2017 Social Forum, an annual meeting convened by the Human Rights Council, is being held next week in Geneva, and will focus on the promotion and protection of human rights in the context of the HIV epidemic and other communicable diseases and epidemics. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WIPO Vaccines Report Contestable, With UN High-Level Panel Misquoted, Advocate Says 10/11/2017 Catherine Saez The World Intellectual Property Organization this week held an event that delved into research, markets and access for vaccines with panels that showed unusual breadth of representation for the UN IP agency. But health advocates have taken issue with the wording of a report released by WIPO at the event. Continue reading -> MSF Secures Deals For Key Hepatitis C Medicines, Price A Fraction Of Branded Drug 31/10/2017 Catherine Saez Médecins Sans Frontières (MSF, Doctors Without Borders) announced today that it has secured deals for two key generic hepatitis C medicines, dropping prices dramatically. Continue reading -> Health Group Challenges Gilead Patents In The US On Grounds Of Lack Of Novelty 25/10/2017 Catherine Saez A health advocacy group today announced that it has challenged a set of United States patents for a hepatitis C medicine. The group says drug maker Gilead Sciences has obtained unmerited patents for sofosbuvir, blocking millions of US patients from affordable treatment. Continue reading -> CARB-X Makes Award For First Topical Antimicrobial; Could Be Used In Emergency Settings 24/10/2017 William New CARB-X, an initiative aimed at accelerating innovation in antibacterial treatment, today announced an award to a company to accelerate development of a new bioengineered antimicrobial intended to be applied directly to affected tissues. This follows an announcement earlier this month of funding another firm to develop a new antibiotic class to treat drug-resistant Gram-negative bacterial infections. Continue reading -> WHO Establishes High-Level Commission On Noncommunicable Diseases 10/10/2017 William New The UN World Health Organization today announced it has established a new high-level global commission on noncommunicable diseases, to be chaired by former WHO director general candidate Sania Nishtar of Pakistan. Continue reading -> 2017 Social Forum Focuses On HIV, Other Epidemics, Access To Health 29/09/2017 Catherine Saez The 2017 Social Forum, an annual meeting convened by the Human Rights Council, is being held next week in Geneva, and will focus on the promotion and protection of human rights in the context of the HIV epidemic and other communicable diseases and epidemics. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
MSF Secures Deals For Key Hepatitis C Medicines, Price A Fraction Of Branded Drug 31/10/2017 Catherine Saez Médecins Sans Frontières (MSF, Doctors Without Borders) announced today that it has secured deals for two key generic hepatitis C medicines, dropping prices dramatically. Continue reading -> Health Group Challenges Gilead Patents In The US On Grounds Of Lack Of Novelty 25/10/2017 Catherine Saez A health advocacy group today announced that it has challenged a set of United States patents for a hepatitis C medicine. The group says drug maker Gilead Sciences has obtained unmerited patents for sofosbuvir, blocking millions of US patients from affordable treatment. Continue reading -> CARB-X Makes Award For First Topical Antimicrobial; Could Be Used In Emergency Settings 24/10/2017 William New CARB-X, an initiative aimed at accelerating innovation in antibacterial treatment, today announced an award to a company to accelerate development of a new bioengineered antimicrobial intended to be applied directly to affected tissues. This follows an announcement earlier this month of funding another firm to develop a new antibiotic class to treat drug-resistant Gram-negative bacterial infections. Continue reading -> WHO Establishes High-Level Commission On Noncommunicable Diseases 10/10/2017 William New The UN World Health Organization today announced it has established a new high-level global commission on noncommunicable diseases, to be chaired by former WHO director general candidate Sania Nishtar of Pakistan. Continue reading -> 2017 Social Forum Focuses On HIV, Other Epidemics, Access To Health 29/09/2017 Catherine Saez The 2017 Social Forum, an annual meeting convened by the Human Rights Council, is being held next week in Geneva, and will focus on the promotion and protection of human rights in the context of the HIV epidemic and other communicable diseases and epidemics. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Health Group Challenges Gilead Patents In The US On Grounds Of Lack Of Novelty 25/10/2017 Catherine Saez A health advocacy group today announced that it has challenged a set of United States patents for a hepatitis C medicine. The group says drug maker Gilead Sciences has obtained unmerited patents for sofosbuvir, blocking millions of US patients from affordable treatment. Continue reading -> CARB-X Makes Award For First Topical Antimicrobial; Could Be Used In Emergency Settings 24/10/2017 William New CARB-X, an initiative aimed at accelerating innovation in antibacterial treatment, today announced an award to a company to accelerate development of a new bioengineered antimicrobial intended to be applied directly to affected tissues. This follows an announcement earlier this month of funding another firm to develop a new antibiotic class to treat drug-resistant Gram-negative bacterial infections. Continue reading -> WHO Establishes High-Level Commission On Noncommunicable Diseases 10/10/2017 William New The UN World Health Organization today announced it has established a new high-level global commission on noncommunicable diseases, to be chaired by former WHO director general candidate Sania Nishtar of Pakistan. Continue reading -> 2017 Social Forum Focuses On HIV, Other Epidemics, Access To Health 29/09/2017 Catherine Saez The 2017 Social Forum, an annual meeting convened by the Human Rights Council, is being held next week in Geneva, and will focus on the promotion and protection of human rights in the context of the HIV epidemic and other communicable diseases and epidemics. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
CARB-X Makes Award For First Topical Antimicrobial; Could Be Used In Emergency Settings 24/10/2017 William New CARB-X, an initiative aimed at accelerating innovation in antibacterial treatment, today announced an award to a company to accelerate development of a new bioengineered antimicrobial intended to be applied directly to affected tissues. This follows an announcement earlier this month of funding another firm to develop a new antibiotic class to treat drug-resistant Gram-negative bacterial infections. Continue reading -> WHO Establishes High-Level Commission On Noncommunicable Diseases 10/10/2017 William New The UN World Health Organization today announced it has established a new high-level global commission on noncommunicable diseases, to be chaired by former WHO director general candidate Sania Nishtar of Pakistan. Continue reading -> 2017 Social Forum Focuses On HIV, Other Epidemics, Access To Health 29/09/2017 Catherine Saez The 2017 Social Forum, an annual meeting convened by the Human Rights Council, is being held next week in Geneva, and will focus on the promotion and protection of human rights in the context of the HIV epidemic and other communicable diseases and epidemics. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Establishes High-Level Commission On Noncommunicable Diseases 10/10/2017 William New The UN World Health Organization today announced it has established a new high-level global commission on noncommunicable diseases, to be chaired by former WHO director general candidate Sania Nishtar of Pakistan. Continue reading -> 2017 Social Forum Focuses On HIV, Other Epidemics, Access To Health 29/09/2017 Catherine Saez The 2017 Social Forum, an annual meeting convened by the Human Rights Council, is being held next week in Geneva, and will focus on the promotion and protection of human rights in the context of the HIV epidemic and other communicable diseases and epidemics. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
2017 Social Forum Focuses On HIV, Other Epidemics, Access To Health 29/09/2017 Catherine Saez The 2017 Social Forum, an annual meeting convened by the Human Rights Council, is being held next week in Geneva, and will focus on the promotion and protection of human rights in the context of the HIV epidemic and other communicable diseases and epidemics. Continue reading -> Posts navigation Older postsNewer posts